(Q36772362)

16 August 2017

1 reference

title

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling (English)

1 reference

16 August 2017

1 reference

Paolo Madeddu

1

1 reference

16 August 2017

Costanza Emanueli

series ordinal

2

1 reference

16 August 2017

Samir El-Dahr

series ordinal

3

1 reference

16 August 2017

publication date

1 April 2007

1 reference

Nature Clinical Practice Nephrology

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

208-221

1 reference

A kallikrein-like enzyme in blood vessels of one-kidney, one clip hypertensive rats

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Role of endogenous bradykinin in human coronary vasomotor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

New, long-acting, potent bradykinin antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Antisense inhibition of the brain kallikrein-kinin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Exclusion of the ACE D/I gene polymorphism as a determinant of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Hypotension in transgenic mice overexpressing human bradykinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Role of bradykinin in angiotensin-converting enzyme knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Normal blood pressure and renal function in mice lacking the bradykinin B(2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Renal segmental microvascular responses to ANG II in AT1A receptor null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

A kallikrein-like enzyme in the aorta of normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

A kallikrein-like enzyme in human vascular tissue.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Tissue kallikrein is synthesized and secreted by human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Immunohistochemical distributions of the tissue kallikrein-kinin system in ischemic and non-ischemic mouse heart.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Kallikrein and kinin receptor genes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

The kallikrein-kinin system in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin receptor ligands: therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Interdependence of calcium signaling and protein tyrosine phosphorylation in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Regulation and functional consequences of endothelial nitric oxide formation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Endothelium-Derived Relaxing Factors and Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Caveolins and the regulation of endothelial nitric oxide synthase in the heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

1 reference

7 January 2021

Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Losartan increases bradykinin levels in hypertensive humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Kallistatin is a potent new vasodilator

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Competitive antagonists of bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Early blockade of bradykinin B2-receptors alters the adult cardiovascular phenotype in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin B2-receptor blockade facilitates deoxycorticosterone-salt hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of bradykinin B1 and B2 receptors in normal blood pressure regulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of kinins in the control of renal papillary blood flow, pressure natriuresis, and arterial pressure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Upregulation of bradykinin B1-receptor expression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Kallikrein-kinin system and blood pressure sensitivity to salt

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

No effect of TaqI polymorphism at the human renal kallikrein (KLK1) locus on normal blood pressure level or variability

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Examination of the role of nitric oxide synthase and renal kallikrein as candidate genes for essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Genetic traits related to hypertension and electrolyte metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

A gene for high urinary kallikrein may protect against hypertension in Utah kindreds

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Cosegregation of blood pressure with a kallikrein gene family polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin B2BKR receptor polymorphism and left-ventricular growth response

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Sequence variation of bradykinin receptors B1 and B2 and association with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Genetically altered animal models in the kallikrein-kinin system

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Human tissue kallikrein induces hypotension in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Functional analysis of human tissue kallikrein in transgenic mouse models

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Increased kallikrein expression protects against cardiac ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

In vivo bradykinin B2 receptor activation reduces renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Enhanced renal function in bradykinin B(2) receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of tissue kallikrein in response to flow in mouse resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of the B(2) receptor of bradykinin in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

The control of microvascular permeability and blood pressure by neutral endopeptidase

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Salt-sensitive hypertension in bradykinin B2 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of the kallikrein-kinin system in the maturation of cardiovascular phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Renovascular hypertension in bradykinin B2-receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Targeting kinin receptors for the treatment of tissue ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0444

7 January 2021

https://api.fatcat.wiki/v0/release/2tieyonc3fbldnkj26wuexf43y

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_2tieyonc3fbldnkj26wuexf43y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2tieyonc3fbldnkj26wuexf43y

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/2tieyonc3fbldnkj26wuexf43y

1 reference

30 July 2022